Bristol-Myers Squibb (BMY) discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.Three key data points gauge Bristol-Myers Squibb or any dividend paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three keys also best tell whether any company has made, is making, and will make money. BMY PriceOver the past year, Bristol-Myers share price dropped about 17.4% from $59.49 to $49.13 as of Friday’s market close. In the past thirty years the company’s share price has never been less than $13.66 nor higher than $81.44.If BMY shares trade in the range of $40.00 to $55.00 this next year, the recent $49.13 share price might rise by $3.87 to reach $53.00 in a year. Of course, BMY price could also drop about the same $3.87 estimated amount, or more.My $3.87 upside estimate is  $0.34 under the median of 1-year price targets from 21 analysts currently tracking BMY for brokers. BMY DividendBristol-Myers Squibb has paid annually increasing quarterly dividends since February 1985.  The most recent $0.60 Q dividend was declared September 10th for shareholders of record October 4th and is payable November 1st.  There’s time to fetch this payout!  A forward looking $2.40 annual dividend yields 4.88% at Friday’s closing price. BMY ReturnsPutting it all together, a $6.27 estimated one year gross gain per share shows up when adding BMY’s $2.40 estimated annual dividend to the estimated price upside of $3.87, making that $6.27 gross gain per share total.A little under $1000 buys us 20 shares at the $49.13 share price.A $10 broker fee (if charged), paid half at purchase and half at sale, might take about $0.50 per share out of the $6.27 annual estimated gross-gain to give us a net gain of $5.77 X 20 shares = $115.40 for about a 11.5% estimated net gain for the year.Furthermore, the $48.80 annual dividend income from $1K invested is just $0.33 under the BMY single share price. By these numbers, Bristol-Myers Squibb may be an ideal dividend dog when its price drops to (or below) $49.00.Then, you might choose to pounce on Bristol-Myers Squibb It is a 137 year-old quarterly dividend-paying New Jersey-based pharmaceutical with a 39 year record paying uninterrupted quarterly dividends.The exact track of Bristol-Myers Squibb’s future price and dividend will entirely be determined by market action.Remember, the true value of any stock is best realized through personal ownership of shares.More By This Author:Current Report: Mercedes Benz Group
Current Report: Kingfisher
Current Report: Johnson Electric